Skip to main content
Sign in
Sign up
Sign in
Sign up
Key Features
Personalized and Rapid Peer Review
Scientific Integrity
Fair Cost and Worldwide Access
Global Dissemination of Your Research
Cutting-Edge Research in Multiple Areas
Complete Stories or Observations
How to Prepare Your Paper for Submission
Journals
Brain Medicine
Genomic Psychiatry
Psychedelics
Submissions
Author Instructions
About Us
Help
News
Key Features
Personalized and Rapid Peer Review
Scientific Integrity
Fair Cost and Worldwide Access
Global Dissemination of Your Research
Cutting-Edge Research in Multiple Areas
Complete Stories or Observations
How to Prepare Your Paper for Submission
Journals
Brain Medicine
Genomic Psychiatry
Psychedelics
Submissions
Author Instructions
About Us
Help
News
Issue Info
Issues
Volume 1: Issue 2
Publication Date:
01 Mar 2025
Online ISSN:
2997-2671
Print ISSN:
2997-268X
Issues
Volume 1: Issue 2
Publication Date:
01 Mar 2025
Online ISSN:
2997-2671
Print ISSN:
2997-268X
Select Issue
COVER
Cover-to-Cover
Abstract
Download PDF
TABLE OF CONTENTS
Table of Contents
Abstract
Download PDF
EDITORIAL
Counting the uncountable: The critical quest to quantify psychedelic medicine's reach
Julio Licinio
DOI:
10.61373/pp025d.0005
Abstract
Download PDF
INNOVATORS & IDEAS: RISING STAR
Alaina M. Jaster: Bridging the gap across preclinical and clinical disciplines in the psychedelic sciences
Alaina M. Jaster
DOI:
10.61373/pp024k.0043
Abstract
Download PDF
Fayzan Rab: What are the economic and public health implications of psychedelic therapies?
Fayzan Rab
DOI:
10.61373/pp024k.0046
Abstract
Download PDF
INNOVATORS & IDEAS: RESEARCH LEADER
Charles L. Raison: Elucidating the role of conscious experience in the therapeutic effects of psychedelics as a means to optimize clinical outcomes
Charles L. Raison
MD
DOI:
10.61373/pp024k.0010
Abstract
Download PDF
COMMENTARY
Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression
Rodolfo Myronn de Melo Rodrigues
DOI:
10.61373/pp024c.0022
Abstract
Download PDF
THOUGHT LEADERS INVITED REVIEW
Effects of ayahuasca on fear and anxiety: cross-talk between 5HT1A and 5HT2A receptors
Lorena Terene Lopes Guerra
,
Rafael Guimarães dos Santos
, and
Jaime Eduardo Cecilio Hallak
DOI:
10.61373/pp024i.0037
Abstract
Download PDF
RESEARCH REPORT
An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States
Syed F. Rab
,
Charles L. Raison
, and
Elliot Marseille
DOI:
10.61373/pp024r.0025
Abstract
Download PDF
What motivates spiritual health practitioners in psychedelic-assisted therapy? A qualitative study and implications for facilitator training practices
Ishan Pasricha
,
Caroline Peacock
,
Roman Palitsky
,
Jaime Clark-Soles
,
Jessica L. Maples-Keller
,
George H. Grant
, and
Deanna M. Kaplan
DOI:
10.61373/pp025r.0008
Abstract
Download PDF
Get Email Alerts
Get eTOC Alerts
Get Ahead of Print Alerts
Xuyu Qian: Understanding human brain development and diseases using human-based approaches
Xuyu Qian
Mirko Manchia: Exploring the biological landscape of psychiatric disorders to innovate clinical management with precision medicine approaches
Mirko Manchia
Randy J. Nelson: Disruption of circadian rhythms on brain function and health
Randy J. Nelson
Michael C. Oldham: Clarifying the cellular and molecular architecture of the human brain in health and disease through gene coexpression analysis
Michael C. Oldham
Mateus Vidigal de Castro: Cellular and genetic determinants of healthy aging and disease resilience
Mateus Vidigal de Castro
Brain Medicine
Genomic Psychiatry
Psychedelics
About us
Author Instructions
Contact Us
Scientific Integrity
Personalized and Rapid Peer Review
Fair Cost and Worldwide Access
Global Dissemination of Your Research
Cutting-Edge Research in Multiple Areas
Complete Stories or Observations
How to Prepare Your Paper for Submission
Powered by
PubFactory
